Becker's Healthcare September 25, 2024
Paige Twenter

Large companies can save millions of dollars by addressing one common misconception about health insurance plans, according to billionaire entrepreneur Mark Cuban.

Mr. Cuban, who entered the pharmaceutical industry as a disruptor in January 2022 with his company, Mark Cuban Cost Plus Drugs, shared his thoughts on pharmacy benefit managers with Becker’s on Sept. 25.

Editor’s note: Responses have been lightly edited for clarity and length.

Question: We’ve talked before about pharmacy benefit managers and why Cost Plus Drugs partners with pass-through PBMs. How do you see the FTC’s recent lawsuit against PBMs influencing the industry?

Mark Cuban: I think it’s a positive step towards transparency. The only real advantage the big PBMs have beyond their size...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Employer, Pharma, Pharma / Biotech
Digital Retail Platforms: The new concept of Pharma to sell directly to patients
Boosting biopharma R&D performance with a next-generation technology stack
Charting the path to patients
External innovation: Biopharma dealmaking to boost R&D productivity
Building a shared vision for pharma R&D–supplier partnerships

Share This Article